Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study

Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study

Background: Long COVID has become a central public health concern. This study characterized the effectiveness of BNT162b2 BA.4/5 bivalent COVID-19 vaccine (bivalent) against long COVID symptoms. Methods: Symptomatic US adult outpatients testing positive for SARS-CoV-2 were recruited between 2 March...

Full description

Bibliographic Details
Main Authors: Manuela Di Fusco, Xiaowu Sun, Kristen E. Allen, Alon Yehoshua, Alexandra Berk, Mary B. Alvarez, Thomas M. Porter, Jinma Ren, Laura Puzniak, Santiago M. C. Lopez, Joseph C. Cappelleri
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Vaccines
Subjects:
BNT162b2
bivalent
BA.4/5
long COVID
PASC
COVID-19
Online Access:https://www.mdpi.com/2076-393X/12/2/183

Internet

https://www.mdpi.com/2076-393X/12/2/183

Similar Items